Home/Pipeline/FELIX System

FELIX System

Mitral Valve Repair (Mitral Regurgitation)

Early FeasibilityActive

Key Facts

Indication
Mitral Valve Repair (Mitral Regurgitation)
Phase
Early Feasibility
Status
Active
Company

About HeartStitch

HeartStitch is a clinical-stage medical device innovator targeting the large and growing market for minimally invasive structural heart procedures. Its core technology platform centers on proprietary suture delivery systems designed to facilitate complex transcatheter and endoscopic suturing, particularly for mitral and tricuspid valve repair. The company is advancing its lead product, the FELIX system, through clinical trials, positioning itself in a competitive but high-reward segment of the cardiology device space. As a private company, it has secured venture funding to progress its pipeline and seeks to address significant unmet needs in valvular heart disease.

View full company profile

About HeartStitch

HeartStitch is a clinical-stage medical device innovator targeting the large and growing market for minimally invasive structural heart procedures. Its core technology platform centers on proprietary suture delivery systems designed to facilitate complex transcatheter and endoscopic suturing, particularly for mitral and tricuspid valve repair. The company is advancing its lead product, the FELIX system, through clinical trials, positioning itself in a competitive but high-reward segment of the cardiology device space. As a private company, it has secured venture funding to progress its pipeline and seeks to address significant unmet needs in valvular heart disease.

View full company profile

Therapeutic Areas